Shots:
- NOWDiagnostics has received a CE mark approval for its ADEXUSDx COVID-19 Ab fingerstick test across 28 countries in the EU. The test first received CE mark for use in moderate/complex laboratory settings on July 28, 2020
- By measuring the presence of SARS-CoV-2 Abs, the ADEXUSDx COVID-19 Test provides precise and reliable results in 15 min. and eliminates the need for buffers, reagents, or additional equipments
- ADEXUSDx COVID-19 Test has demonstrated a high level of analytical performance with 95.6% sensitivity and 98.5% specificity and is under FDA’s review for EUA
Click here to read full press release/ article | Ref: PRNewswire | Image: NOW Diagnostics
The post NOWDiagnostics Receives CE Mark for its ADEXUSDx COVID-19 Antibody Fingerstick Test first appeared on PharmaShots.
